Janus Henderson Global Life Sciences Fund
Limited financial coverage for JAGLX.
Not enough data to compute a meaningful composite — typical for foreign-listed ADRs, recent IPOs, or thinly-covered small caps. Live quote, chart, and any available stats still render below.
Price Chart
About the company
The Janus Henderson Global Life Sciences Fund primarily focuses its investment strategy on companies operating within the life sciences field. Typically, at least 80% of its net assets (which includes any borrowed funds for investment) are allocated to firms that the portfolio manager believes exhibit a life sciences orientation. Additionally, as a fundamental investment principle, the fund generally commits a minimum of 25% of its total assets to businesses officially classified within the "life sciences" sector.
- IPO
- 1998
- HQ
- Denver, CO, US
Get TickerSpark's AI analysis on JAGLX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $6.13B
- Div Yield
- 3.97%
- 52W High
- $93.51
- 52W Low
- $68.04
- 50D MA
- $87.01
- 200D MA
- $81.70
- Beta
- 0.66
- RSI (14)
- 62
- Avg Volume
- 0
No earnings-call transcripts are available for JAGLX yet.
- Free Float
- 0.0%
- Shares Outstanding
- 66.81M
- Float Shares
- 0
of shares held by institutions
1 13F filers
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Trust Department Mb Financial Bank N A | 190 | 0 |
Our JAGLX coverage
Recent articles, reports, and earnings notes.
No research on JAGLX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate JAGLX report →